Andrew Campbell, MD, Pediatric Hematology & Oncology, Washington, DC, Children's National Hospital


Pediatric Hematology & Oncology Washington, DC

Medical Director, Sickle Cell Program, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC

Dr. Campbell is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Campbell's full profile

Already have an account?

  • Office

    Children's National Medical Center
    111 Michigan Avenue
    Washington, DC 20010
    Phone(202) 476-2800
    Fax(202) 476-5685
  • Is this information wrong?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pediatrics, 1996 - 1999
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1996

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2020 - 2022
  • DC State Medical License
    DC State Medical License 2017 - 2022
  • MD State Medical License
    MD State Medical License 2017 - 2022
  • MI State Medical License
    MI State Medical License 2002 - 2018
  • IL State Medical License
    IL State Medical License 1999 - 2005
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Top Doctors Castle Connolly Medical LTD, 2018
  • 2018 Best Doctors in America, Pediatric Hematology/Oncology Best Doctors Inc., 2013-2018

Clinical Trials

Publications & Presentations


Journal Articles

  • Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana  
    Antwi-Boasiako C, Campbell AD, Vascular Health and Risk Management, 9/6/2018


  • Economic Burden of End Organ Damage Among Patients with Sickle Cell Disease in the US
    Andrew D. Campbell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019


  • An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Re... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Outcomes in Children with Severe Vasculopathy from Sickle Cell Anemia after Treatment with Chronic Transfusion, Surgical Revascularization and/or Allogenic Hematopoeti... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Potential Treatment for Sickle Cell Disease
    Potential Treatment for Sickle Cell DiseaseNovember 10th, 2011

Professional Memberships

Hospital Affiliations